Send to

Choose Destination
Neurobiol Dis. 2010 Feb;37(2):275-83. doi: 10.1016/j.nbd.2009.10.003. Epub 2009 Oct 12.

Optimizing the success of cell transplantation therapy for stroke.

Author information

Department of Neurosurgery and Stanford Stroke Center, Stanford University School of Medicine, Stanford, CA 94305-5487, USA.


Stem cell transplantation has evolved as a promising experimental treatment approach for stroke. In this review, we address the major hurdles for successful translation from basic research into clinical applications and discuss possible strategies to overcome these issues. We summarize the results from present pre-clinical and clinical studies and focus on specific areas of current controversy and research: (i) the therapeutic time window for cell transplantation; (ii) the selection of patients likely to benefit from such a therapy; (iii) the optimal route of cell delivery to the ischemic brain; (iv) the most suitable cell types and sources; (v) the potential mechanisms of functional recovery after cell transplantation; and (vi) the development of imaging techniques to monitor cell therapy.

[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center